The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
The Associated Press on MSN9d
Novo Nordisk cuts Wegovy prices, following Eli Lilly on ZepboundMakers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind ...
Wegovy’s maker, Novo Nordisk, is charging $499 per month for its direct-to-consumer product. Customers can’t get their health insurance to pay for the either Eli Lilly’s Zepbound vials or ...
Last week, Eli Lilly, the maker of Zepbound, also cut prices for its starter dose to $349 per month. Larger doses will now cost $499 per month through the company’s self-pay program.
Novo Nordisk is... Consumers can buy Zepbound and Wegovy direct from drugmakers if they pay cash Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback